AxSpA remission on TNFi seen in half of patients with comorbid IBDMay 25, 2023GastroenterologyRheumatology
FDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023PediatricsRare DiseasesDermatologyGastroenterologyRheumatology
FDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023PediatricsDermatologyGastroenterologyRheumatologyRare Diseases
Biomarkers for measuring lupus nephritis treatment response gain groundMay 19, 2023NephrologyRheumatology
Meta-analysis examines cancer risk concern for JAK inhibitorsApril 26, 2023PediatricsGastroenterologyDermatologyRheumatology
